title: Evaluation of the effects of treating dairy cows with meloxicam at calving on retained fetal membranes risk.
abstract: Some non-steroidal anti-inflammatory drugs increase the risk of retained fetal membranes. This is the first study to investigate the effects of meloxicam on the risk of retained fetal membranes. Administration of meloxicam to dairy cattle immediately following calving revealed no differences in the incidence of retained fetal membranes between meloxicam-treated and untreated animals. There was no difference between the 2 groups in the incidence of periparturient diseases following calving. Meloxicam can be used on the day of calving in lactating cows without increasing the risk of retained fetal membranes.
authors.affiliation: Department of Population Medicine, University of Guelph, Guelph, Ontario N1G 2W1 (Newby, Renaud, Duffield); Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4 (Tremblay).
authors.forename: Nathalie C
authors.initials: NC
authors.lastname: Newby
authors.affiliation: Department of Population Medicine, University of Guelph, Guelph, Ontario N1G 2W1 (Newby, Renaud, Duffield); Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4 (Tremblay).
authors.forename: David
authors.initials: D
authors.lastname: Renaud
authors.affiliation: Department of Population Medicine, University of Guelph, Guelph, Ontario N1G 2W1 (Newby, Renaud, Duffield); Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4 (Tremblay).
authors.forename: Robert
authors.initials: R
authors.lastname: Tremblay
authors.affiliation: Department of Population Medicine, University of Guelph, Guelph, Ontario N1G 2W1 (Newby, Renaud, Duffield); Boehringer Ingelheim (Canada) Ltd., Burlington, Ontario L7L 5H4 (Tremblay).
authors.forename: Todd F
authors.initials: TF
authors.lastname: Duffield
mesh_terms: D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects* / Q000627:therapeutic use; D002417:Cattle; D002418:Cattle Diseases / Q000139:chemically induced* / Q000453:epidemiology; D005321:Extraembryonic Membranes; D005260:Female; D015994:Incidence; D008297:Male; D000077239:Meloxicam; D007744:Obstetric Labor Complications / Q000139:chemically induced / Q000453:epidemiology / Q000662:veterinary*; D058725:Peripartum Period; D011247:Pregnancy; D012307:Risk Factors; D013843:Thiazines / Q000009:adverse effects* / Q000627:therapeutic use; D013844:Thiazoles / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D013843:Thiazines; D013844:Thiazoles; D000077239:Meloxicam